碘I-131,iobenguane,1毫米A9590辐射RA-223二氯化物,治疗性,由Microcurie a9606 lutetium lu 177 vipivivotide tetraxetan,治疗性,1毫米,1毫米A9607 radiopharmaceutical a96,否则,否则,否则不明显A99。 Filgrastim-txid(NYPOZI),生物仿制药,1微克C9173注射,贝伐单抗,0.25 mg C9257注射,葡萄糖酶,10个单位C9293 C9293未分类药物或生物学的药物C9399 c9399 c9399 c9399 c9399 c9399 c9399 c9399 c9399 c9399 c9399 c9399 c9399受伤 BUSULFAN, 1 MG J0594 INJECTION, LEUCOVORIN CALCIUM, PER 50 MG J0640 INJECTION, LEVOLEUCOVORIN, NOT OTHERWISE SPECIFIED, 0.5 MG J0641 INJECTION, LEVOLEUCOVORIN (KHAPZORY), 0.5 MG J0642 Injection, imetelstat, 1 mg J0870 INJECTION, DARBEPOETIN ALFA, 1 MICROGRAM (非用途)J0881注射,epoetin alfa,(非用途),1000个单位J0885 j0885注射素,epoetin beta,1微克,(无ESRD使用)J0888注射,DiCitabine(Sun Pharma)不适用于J0894,1 MG J094,1 MG J09393939393 J0894注射,denosumab,1 mg J0897注射,甲基促苯甲酸乙酸酯,1毫克J1010注射,Elranatamab-BCMM,1 mg J1323注射,fosaprepitant,Fosaprepitant(二型),1 mg J1434 INFILESIM,filgrastim(g-c.-cuder)(g-c.-cuder),排除在外 J1442 INJECTION, TBO-FILGRASTIM, 1 MICROGRAM J1447 INJECTION, TRILACICLIB, 1 MG J1448 Injection, eflapegrastim-xnst, 0.1 mg J1449 INJECTION, FOSNETUPITANT 235 MG AND PALONOSETRON 0.25 MG J1454 Injection, fosaprepitant (teva), not therapeutically相当于J1453,1 mg J1456注射,免疫球蛋白,(γPLEX),静脉注射,未脊髓裂(例如,液体),500 mg J1557
c9145无验证需要Aponvie注射,Aprepitant,(aponvie),1 mg ind,aponvie,1 mg C9248 no Auth。需要注射CLEVIPREX,CLEVIDIPINE BUTYRATE,1 mg ING,CLEVIDIPINE BUTYRATE C9254 NO AUTH。所需的Vimpat注射,Lacosamide,1毫克注射,Lacosamide C9257 auth需要注射avastin注射,贝伐单抗,0.25 mg贝伐单抗注射C9285否auth。必需的Synera Lidocaine 70 mg/Tetracaine 70 mg,每个贴片贴片,利多卡因/四卡因C9290无验证。需要注射膨胀,布比卡因脂质体,1毫克ING,布比卡因脂质体C9293没有auth。需要注射voraxaze,葡萄糖酶,10个单位注射,葡萄糖酶C9399 auth需要未分类的代码未分类的药物或生物学未分类药物或生物C9460否AUTH。需要肯格雷注射,cangrelor,1毫克注入,Cangrelor C9462 auth需要Baxdela注射,Delafloxacin,1毫克注入,Delafloxacin C9488 C9488 auth Sirri auth Sirri vaprisol需要注入,Conivaptan盐酸盐,1 mg Conivaptan Hclaptan Hcl hcl
